4//SEC Filing
Smith Jason Drew 4
Accession 0001437749-25-028705
CIK 0001668243other
Filed
Sep 8, 8:00 PM ET
Accepted
Sep 9, 6:32 PM ET
Size
8.2 KB
Accession
0001437749-25-028705
Insider Transaction Report
Form 4
Smith Jason Drew
General Counsel
Transactions
- Exercise/Conversion
Ordinary Shares
2025-09-07+3,333→ 44,825 total - Sale
Ordinary Shares
2025-09-08$19.11/sh−1,520$29,047→ 43,305 total - Exercise/Conversion
Restricted Stock Units
2025-09-07−3,333→ 3,334 total→ Ordinary Shares (3,333 underlying)
Footnotes (3)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.
- [F2]Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units.
- [F3]The reporting person was granted RSUs on September 7, 2023 representing 10,000 ordinary shares. The RSUs will vest in three equal annual installments from September 7, 2024.
Documents
Issuer
UroGen Pharma Ltd.
CIK 0001668243
Entity typeother
Related Parties
1- filerCIK 0001821479
Filing Metadata
- Form type
- 4
- Filed
- Sep 8, 8:00 PM ET
- Accepted
- Sep 9, 6:32 PM ET
- Size
- 8.2 KB